Abiomed, Inc. - stock earnings

ABMD Quarterly earnings

DateEarningsRevenue
2022Q3 106.1 million USD 265.9 million USD
2022Q2 54.6 million USD 277.1 million USD
2022Q1 60.3 million USD 269.9 million USD
2021Q4 45.8 million USD 261.2 million USD
2021Q3 57.0 million USD 248.1 million USD
2021Q2 -26.5 million USD 252.6 million USD
2021Q1 56.9 million USD 241.2 million USD
2020Q4 61.9 million USD 231.7 million USD
2020Q3 62.2 million USD 209.8 million USD

ABMD Yearly earnings

DateEarningsRevenue
2022 136.5 million USD 1.0 billion USD
2021 225.5 million USD 847.5 million USD
2020 203.0 million USD 840.9 million USD
2019 259.0 million USD 769.4 million USD
2018 112.2 million USD 593.7 million USD

ABMD

Price: $381.02

52 week price:
219.85
381.99

Earnings Per Share: 6.27 USD

P/E Ratio: 65.36

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Volume: 15.7 million

Ebitda: 47.5 million

Market Capitalization: 17.2 billion

Links: